Business
Bristol-Myers--maker of such products as Ban, Excedrin and Drano--and Squibb--a prescription drug manufacturer that makes a widely used high blood pressure drug--said Thursday that they have agreed to a $12-billion stock-swap merger.
July 28, 1989
Bristol-Myers Squibb Co., whose billing methods are being probed by U.S. government authorities, said Tuesday that it was investigating its marketing practices to determine whether it violated anti-kickback laws and cheated state-run Medicaid programs.
July 23, 2003
In a surprise announcement today, Bristol-Myers Co. and Squibb Corp. said they have agreed to merge in an $11-billion stock-swap deal that would create the world’s second-largest pharmaceutical concern.
July 27, 1989
Jan Leschly has resigned as president of Squibb Corp., saying his personal goals “are not realistic” under the company’s merger with Bristol-Myers Co.
Oct. 13, 1989
Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing practices.
Sept. 29, 2007
Moving to broaden its business base in Europe, Bristol-Myers Squibb Co. has entered agreements to acquire a minority stake in UPSA Group and to develop the French company’s non-prescription drug operations worldwide, the companies announced Friday.
Sept. 1, 1990
Bristol-Myers, Squibb Holders OK Merger: Bristol-Myers Co. and Squibb Corp. stockholders approved their companies’ $11.5-billion merger into Bristol-Myers Squibb Co., which will be world’s second-largest pharmaceuticals company.
Oct. 4, 1989
Amgen Inc. shares tumbled Thursday after Bristol-Myers Squibb Co. denied rumors that it is in talks to acquire the biotechnology company.
Feb. 10, 1995
The drug maker’s deal allows the company to defer prosecution in the accounting scandal. Two former executives are indicted.
June 16, 2005
The deal to resolve civil fraud claims consists of a $100-million fine and a payment to a fund for shareholders.
Aug. 5, 2004